13824 Federal Register / Vol. 72, No. 56 / Friday, March 23, 2007 / Notices 

The company plans to manufacture 

the listed controlled substances in bulk 

for sale to its customers. 

No comments or objections have been 

received. DEA has considered the 

factors in 21 U.S.C. 823(a) and 

determined that the registration of 

Johnson Matthey, Inc to manufacture 

the listed basic classes of controlled 

substances is consistent with the public 

interest at this time. DEA has 

investigated Johnson Matthey, Inc to 

ensure that the company’s registration is 

consistent with the public interest. The 

investigation has included inspection 

and testing of the company’s physical 

security systems, verification of the 

company’s compliance with state and 

local laws, and a review of the 

company’s background and history. 

Therefore, pursuant to 21 U.S.C. 823, 

and in accordance with 21 CFR 1301.33, 

the above named company is granted 

registration as a bulk manufacturer of 

the basic classes of controlled 

substances listed. 

Dated: March 19, 2007. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. E7–5401 Filed 3–22–07; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Manufacturer of Controlled 

Substances; Notice of Registration 

By Notice dated November 21, 2006, 

and published in the Federal Register 

on December 1, 2006, (71 FR 69592–

69593), National Center for Natural 

Products Research-NIDA MProject, 

University of Mississippi, 135 Coy 

Waller Lab Complex, University, 

Mississippi 38677, made application by 

renewal to the Drug Enforcement 

Administration (DEA) to be registered as 

a bulk manufacturer of the basic classes 

of controlled substances listed in 

schedule I: 

Drug Schedule 

Marihuana (7360) ......................... I 

Tetrahydrocannabinols (7370) ..... I 

The company plans to cultivate 

marihuana for the National Institute of 

Drug Abuse for research approved by 

the Department of Health and Human 

Services. 

No comments or objections have been 

received. DEA has considered the 

factors in 21 U.S.C. 823(a) and 

determined that the registration of 

National Center for Natural Products 

Research-NIDA MProject, University of 

Mississippi to manufacture the listed 

basic classes of controlled substances is 

consistent with the public interest at 

this time. DEA has investigated National 

Center for Natural Products ResearchNIDA MProject, University of 

Mississippi to ensure that the 

company’s registration is consistent 

with the public interest. The 

investigation has included inspection 

and testing of the company’s physical 

security systems, verification of the 

company’s compliance with state and 

local laws, and a review of the 

company’s background and history. 

Therefore, pursuant to 21 U.S.C. 823, 

and in accordance with 21 CFR 1301.33, 

the above named company is granted 

registration as a bulk manufacturer of 

the basic classes of controlled 

substances listed. 

Dated: March 8, 2007. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. E7–5398 Filed 3–22–07; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Manufacturer of Controlled 

Substances; Notice of Registration 

By Notice dated November 21, 2006, 

and published in the Federal Register 

on December 1, 2006, (71 FR 69593), 

Norac, Inc., 405 S. Motor Avenue, P.O. 

Box 577, Azusa, California 91702, made 

application by renewal to the Drug 

Enforcement Administration (DEA) to 

be registered as a bulk manufacturer of 

Tetrahydrocannabinols (7370), a basic 

class of controlled substance listed in 

schedule I. 

The company plans to manufacture 

the listed controlled substance in bulk 

for formulation into the pharmaceutical 

controlled substance Marinol. 

No comments or objections have been 

received. DEA has considered the 

factors in 21 U.S.C. 823(a) and 

determined that the registration of 

Norac, Inc to manufacture the listed 

basic classes of controlled substances is 

consistent with the public interest at 

this time. DEA has investigated Norac, 

Inc to ensure that the company’s 

registration is consistent with the public 

interest. The investigation has included 

inspection and testing of the company’s 

physical security systems, verification 

of the company’s compliance with State 

and local laws, and a review of the 

company’s background and history. 

Therefore, pursuant to 21 U.S.C. 823, 

and in accordance with 21 CFR 1301.33, 

the above named company is granted 

registration as a bulk manufacturer of 

the basic classes of controlled 

substances listed. 

Dated: March 8, 2007. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. E7–5392 Filed 3–22–07; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Manufacturer of Controlled 

Substances; Notice of Application; 

Correction 

By Notice dated January 16, 2007, and 

published in the Federal Register on 

January 23, 2007, (72 FR 2907), the 

listing of controlled substances 

Tetrahydrocannabinols (7370), was 

incorrectly listed as a basic class of 

controlled substance listed in schedule 

II, for Organix Inc., 240 Salem Street, 

Woburn, Massachusetts 01801. The 

Notice of Application should be 

corrected to a basic class of controlled 

substance listed in schedule I. 

Dated: March 8, 2007. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. E7–5385 Filed 3–22–07; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Manufacturer of Controlled 

Substances; Notice of Registration 

By Notice dated November 28, 2006, 

and published in the Federal Register 

on December 7, 2006, (71 FR 70987), 

Organix Inc., 240 Salem Street, Woburn, 

Massachusetts 01801, made application 

by renewal to the Drug Enforcement 

Administration (DEA) to be registered as 

a bulk manufacturer of Cocaine (9041), 

a basic class of controlled substance 

listed in schedule II. 

The company plans to manufacture a 

chemical that is a derivative of cocaine 

that will be sold to another company for 

research purposes. 

No comments or objections have been 

received. DEA has considered the 

factors in 21 U.S.C. 823(a) and 

determined that the registration of 


sroberts on PROD1PC70 with NOTICES